PAREXEL Announces Definitive Agreement to Acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialisation and medical affairs servicesLONDON, February 2, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC (“TMAC”), a leading provider of outsourced medical affairs services to the pharmaceutical, biotechnology, and medical device industries. The acquisition is expected to close in February. Terms of the transaction... Source: RealWire

Read More